etidronate has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, JC | 1 |
| Appleton, RE | 1 |
| Abernethy, L | 1 |
| Meythaler, JM | 1 |
| Korkor, AB | 1 |
| Nanda, T | 1 |
| Kumar, NA | 1 |
| Fallon, M | 1 |
2 other studies available for etidronate and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Myositis ossificans complicating severe Guillain-Barré syndrome.
Topics: Adolescent; Cerebrospinal Fluid Proteins; Etidronic Acid; Humans; Immunoglobulins, Intravenous; Male | 1997 |
Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Topics: Adult; Aged; Bone and Bones; Calcitonin; Calcium; Drug Therapy, Combination; Etidronic Acid; Humans; | 1986 |